130 related articles for article (PubMed ID: 2158652)
1. Neurokinin A. A pharmacological study.
Regoli D; Rhaleb NE; Dion S; Tousignant C; Rouissi N; Jukic D; Drapeau G
Pharmacol Res; 1990; 22(1):1-14. PubMed ID: 2158652
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity studies of neurokinin A.
Rovero P; Pestellini V; Rhaleb NE; Dion S; Rouissi N; Tousignant C; Télémaque S; Drapeau G; Regoli D
Neuropeptides; 1989; 13(4):263-70. PubMed ID: 2546091
[TBL] [Abstract][Full Text] [Related]
3. A potent and selective agonist for NK-2 tachykinin receptor.
Rovero P; Pestellini V; Patacchini R; Giuliani S; Santicioli P; Maggi CA; Meli A; Giachetti A
Peptides; 1989; 10(3):593-5. PubMed ID: 2550911
[TBL] [Abstract][Full Text] [Related]
4. A pharmacological study of NK1 and NK2 tachykinin receptor characteristics in the rat isolated urinary bladder.
Hall JM; Flowers JM; Morton IK
Br J Pharmacol; 1992 Nov; 107(3):777-84. PubMed ID: 1282072
[TBL] [Abstract][Full Text] [Related]
5. The hamster isolated trachea: a new preparation for studying NK-2 receptors.
Maggi CA; Patacchini R; Rovero P; Meli A
Eur J Pharmacol; 1989 Aug; 166(3):435-40. PubMed ID: 2478373
[TBL] [Abstract][Full Text] [Related]
6. Neurokinin receptors (NK1, NK2) in the mouse: a pharmacological study.
Nsa Allogho S; Nguyen-Le XK; Gobeil F; Pheng LH; Regoli D
Can J Physiol Pharmacol; 1997 Jun; 75(6):552-7. PubMed ID: 9276127
[TBL] [Abstract][Full Text] [Related]
7. Characterization of neurokinin effects and receptor selectivity in human isolated bronchi.
Naline E; Devillier P; Drapeau G; Toty L; Bakdach H; Regoli D; Advenier C
Am Rev Respir Dis; 1989 Sep; 140(3):679-86. PubMed ID: 2476956
[TBL] [Abstract][Full Text] [Related]
8. The actions of neurokinins and substance P in canine pylorus, antrum and duodenum.
Allescher HD; Kostolanska F; Tougas G; Fox JE; Regoli D; Drapeau G; Daniel EE
Peptides; 1989; 10(3):671-9. PubMed ID: 2476789
[TBL] [Abstract][Full Text] [Related]
9. In vivo pharmacology of [beta Ala8]neurokinin A-(4-10), a selective NK-2 tachykinin receptor agonist.
Maggi CA; Giuliani S; Ballati L; Rovero P; Abelli L; Manzini S; Giachetti A; Meli A
Eur J Pharmacol; 1990 Feb; 177(1-2):81-6. PubMed ID: 2160369
[TBL] [Abstract][Full Text] [Related]
10. Neurokinins produce selective venoconstriction via NK-3 receptors in the rat mesenteric vascular bed.
D'Orléans-Juste P; Claing A; Télémaque S; Warner TD; Regoli D
Eur J Pharmacol; 1991 Nov; 204(3):329-34. PubMed ID: 1723050
[TBL] [Abstract][Full Text] [Related]
11. Potent and highly selective neurokinin antagonists.
Ward P; Ewan GB; Jordan CC; Ireland SJ; Hagan RM; Brown JR
J Med Chem; 1990 Jul; 33(7):1848-51. PubMed ID: 1694545
[No Abstract] [Full Text] [Related]
12. Neurokinin receptors and mucosal ion transport in porcine jejunum.
Parsons AM; Seybold VS; Chandan R; Vogt J; Larson AA; Murray CR; Soldani G; Brown DR
J Pharmacol Exp Ther; 1992 Jun; 261(3):1213-21. PubMed ID: 1376358
[TBL] [Abstract][Full Text] [Related]
13. Mammalian tachykinins stimulate rat uterus by activating NK-2 receptors.
Pennefather JN; Zeng XP; Gould D; Hall S; Burcher E
Peptides; 1993; 14(2):169-74. PubMed ID: 7683398
[TBL] [Abstract][Full Text] [Related]
14. Effects of tachykinins on myenteric neurones of the guinea-pig gastric corpus: involvement of NK-3 receptors.
Schemann M; Kayser H
Pflugers Arch; 1991 Dec; 419(6):566-71. PubMed ID: 1724075
[TBL] [Abstract][Full Text] [Related]
15. Tachykinins mediate contraction of the human lower esophageal sphincter in vitro via activation of NK2 receptors.
Huber O; Bertrand C; Bunnett NW; Pellegrini CA; Nadel JA; Nakazato P; Debas HT; Geppetti P
Eur J Pharmacol; 1993 Aug; 239(1-3):103-9. PubMed ID: 8223885
[TBL] [Abstract][Full Text] [Related]
16. Classification of tachykinin receptors in muscularis mucosae of opossum oesophagus.
Daniel EE; Cipris S; Manaka Y; Bowker P; Regoli D
Br J Pharmacol; 1989 Aug; 97(4):1013-8. PubMed ID: 2477100
[TBL] [Abstract][Full Text] [Related]
17. Evidence for tachykinin NK-2 receptors in guinea-pig airways from binding and functional studies, using [125I]-[Lys5,Tyr(I2)7,MeLeu9,Nle10]-NKA(4-10).
Zeng XP; Lavielle S; Burcher E
Neuropeptides; 1994 Jan; 26(1):1-9. PubMed ID: 7512696
[TBL] [Abstract][Full Text] [Related]
18. Selective agonists for receptors of substance P and related neurokinins.
Regoli D; Dion S; Rhaleb NE; Rouissi N; Tousignant C; Jukic D; D'Orleans-Juste P; Drapeau G
Biopolymers; 1989 Jan; 28(1):81-90. PubMed ID: 2470440
[TBL] [Abstract][Full Text] [Related]
19. Respiratory actions of tachykinins in the nucleus of the solitary tract: characterization of receptors using selective agonists and antagonists.
Mazzone SB; Geraghty DP
Br J Pharmacol; 2000 Mar; 129(6):1121-31. PubMed ID: 10725260
[TBL] [Abstract][Full Text] [Related]
20. Receptors for neurokinins in human bronchus and urinary bladder are of the NK-2 type.
Dion S; Rouissi N; Nantel F; Drapeau G; Regoli D; Naline E; Advenier C
Eur J Pharmacol; 1990 Mar; 178(2):215-9. PubMed ID: 1691713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
